Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) closed at $0.71 in the last session, down -1.23% from day before closing price of $0.72. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 7.17 million shares were traded. LXRX stock price reached its highest trading level at $0.7599 during the session, while it also had its lowest trading level at $0.7018.
Ratios:
We take a closer look at LXRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.43 and its Current Ratio is at 7.45. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 17, 2024, initiated with a Buy rating and assigned the stock a target price of $10.
On April 30, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $5.
On March 07, 2023, Jefferies started tracking the stock assigning a Hold rating and target price of $3.Jefferies initiated its Hold rating on March 07, 2023, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when COATS LONNEL bought 300,000 shares for $1.60 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LXRX now has a Market Capitalization of 258358320 and an Enterprise Value of 99884336. For the stock, the TTM Price-to-Sale (P/S) ratio is 48.79 while its Price-to-Book (P/B) ratio in mrq is 1.45. Its current Enterprise Value per Revenue stands at 19.102 whereas that against EBITDA is -0.474.
Stock Price History:
Over the past 52 weeks, LXRX has reached a high of $3.73, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -40.30%, while the 200-Day Moving Average is calculated to be -57.49%.
Shares Statistics:
According to the various share statistics, LXRX traded on average about 4.07M shares per day over the past 3-months and 6789430 shares per day over the past 10 days. A total of 361.49M shares are outstanding, with a floating share count of 168.72M. Insiders hold about 53.33% of the company’s shares, while institutions hold 29.64% stake in the company. Shares short for LXRX as of 1732838400 were 31530008 with a Short Ratio of 7.75, compared to 1730332800 on 28649978. Therefore, it implies a Short% of Shares Outstanding of 31530008 and a Short% of Float of 19.35.
